![Colin and Linda](https://retinauk.org.uk/wp-content/uploads/2023/09/Page-16-17-Colin-and-Linda-scaled-e1706090361875.jpg)
Meet our Trustee: Colin McArthur
Colin McArthur re-joined the board in 2024 after serving as a trustee between (January 2008 and September 2019).
Search results
Colin McArthur re-joined the board in 2024 after serving as a trustee between (January 2008 and September 2019).
Dr Nikolas Pontikos is a Senior Research Fellow at UCL Institute of Ophthalmology, and has been working on inherited retinal conditions for several years.
This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing
You may have heard that a cell-based treatment approach (sometimes referred to as a “stem cell treatment”), developed by a company called ReNeuron, is being tested in a clinical trial at Oxford Eye Hospital and other centres in the US and Europe.
Whether you are looking for practical information or emotional support, online, by phone or face-to-face, we’re here to help.
Have you ever been tempted to take part in the TCS London Marathon? In 2022 the TCS London Marathon raised £58.3 million for charity so it’s a vital source of income.
Martin's son was diagnosed with Stargardt’s at a young age which has led Martin to take a close interest in the progress of research into Retinal disease.
Roger has retinitis pigmentosa, as do his son, mother and grandfather. He was officially diagnosed aged 16.
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
We’re all still buzzing from our recent conferences. We do hope you enjoyed them as much as we did. If you weren’t able to join us, then you can watch or listen to the recordings on our website.